On August 23, 2010, a new record at TRIUMF was born: the beam line 1 extraction probe 1 (Ex1) foil was replaced after a lifetime of almost seventeen weeks, far exceeding the lifetime of its predecessors!
As of September 6, 2010, after years of working alongside TRIUMF experts, the British Columbia Cancer Agency is undertaking the task of producing medical isotopes on its own.
TRIUMF and our partners, the UBC Brain Research Centre, and MDS Nordion, are proud to showcase nuclear-medicine research through support and involvement in Science World's newest exhibition—BODY WORLDS & The Brain.
On Sept. 2, 2010, the Consul General of Japan for Vancouver visited TRIUMF. Mr Hideki Ito met with leading researchers from Japan and Canada and learned about the history of strong partnerships with TRIUMF.
On August 4, the TeraChem* 2010 Committee announced the winners of the Marino Nicolini Prize. One of the winners is Dr. Suzanne Lapi (Suzy), who submitted a paper based on the MoRe isotope-separation project.
On your way to work last week, you might have noticed a large pile of moved earth, a gaping manhole, and a set of skilled engineers working out front across from the TRIUMF sign...
A federal investment of ~$1M to support innovative medical and pharmaceutical research at TRIUMF was announced today by the Honourable Lynne Yelich, Minister of State for Western Economic Diversification Canada.
IEEE has recognized the extraction of the first high-energy proton beams from the TRIUMF main cyclotron on December 15, 1974 as an historic engineering milestone.
Individuals with Parkinson’s disease were more likely to have a response to a placebo if they were told they had higher odds of receiving an active drug, according to new work by TRIUMF partners.